Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care July 2000 23:888-892; doi:10.2337/diacare.23.7.888
Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care July 2000 23:893-897; doi:10.2337/diacare.23.7.893
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy. Diabetes Care July 2000 23:1031-1032; doi:10.2337/diacare.23.7.1031
Risk for silent celiac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care July 2000 23:1027-1028; doi:10.2337/diacare.23.7.1027
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care July 2000 23:888-892; doi:10.2337/diacare.23.7.888
Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive
normoalbuminuric type 1 diabetic patients. Diabetes Care July 2000 23:989-993; doi:10.2337/diacare.23.7.989
Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care July 2000 23:912-918; doi:10.2337/diacare.23.7.912
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Diabetes Care July 2000 23:979-983; doi:10.2337/diacare.23.7.979
European Association for the Study of Diabetes Annual Meeting, 1999: treatment modalities. Diabetes Care July 2000 23:1012-1017; doi:10.2337/diacare.23.7.1012
Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of
diabetes and precursors. Diabetes Care July 2000 23:905-911; doi:10.2337/diacare.23.7.905
Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose. Diabetes Care July 2000 23:1037-1038; doi:10.2337/diacare.23.7.1037
Risk for silent celiac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care July 2000 23:1027-1028; doi:10.2337/diacare.23.7.1027
Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care July 2000 23:962-968; doi:10.2337/diacare.23.7.962
Risk for silent celiac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care July 2000 23:1027-1028; doi:10.2337/diacare.23.7.1027
Risk for silent celiac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care July 2000 23:1027-1028; doi:10.2337/diacare.23.7.1027
No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients. Diabetes Care July 2000 23:1045-1046; doi:10.2337/diacare.23.7.1045
Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care July 2000 23:951-956; doi:10.2337/diacare.23.7.951
Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care July 2000 23:962-968; doi:10.2337/diacare.23.7.962
No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients. Diabetes Care July 2000 23:1045-1046; doi:10.2337/diacare.23.7.1045
No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients. Diabetes Care July 2000 23:1045-1046; doi:10.2337/diacare.23.7.1045
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis
Study. Diabetes Care July 2000 23:1006-1011; doi:10.2337/diacare.23.7.1006
High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type
1 diabetes. Diabetes Care July 2000 23:1025-1026; doi:10.2337/diacare.23.7.1025
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care July 2000 23:893-897; doi:10.2337/diacare.23.7.893
Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive
normoalbuminuric type 1 diabetic patients. Diabetes Care July 2000 23:989-993; doi:10.2337/diacare.23.7.989
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German
BABYDIAB Study. Diabetes Care July 2000 23:969-974; doi:10.2337/diacare.23.7.969
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care July 2000 23:888-892; doi:10.2337/diacare.23.7.888
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal
people from a group of remote homeland communities. Diabetes Care July 2000 23:898-904; doi:10.2337/diacare.23.7.898
Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction. Diabetes Care July 2000 23:882-883; doi:10.2337/diacare.23.7.882
Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care July 2000 23:951-956; doi:10.2337/diacare.23.7.951
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care July 2000 23:943-950; doi:10.2337/diacare.23.7.943
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis
Study. Diabetes Care July 2000 23:1006-1011; doi:10.2337/diacare.23.7.1006
Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care July 2000 23:912-918; doi:10.2337/diacare.23.7.912
Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive
normoalbuminuric type 1 diabetic patients. Diabetes Care July 2000 23:989-993; doi:10.2337/diacare.23.7.989
Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of
diabetes and precursors. Diabetes Care July 2000 23:905-911; doi:10.2337/diacare.23.7.905
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis
Study. Diabetes Care July 2000 23:1006-1011; doi:10.2337/diacare.23.7.1006
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care July 2000 23:943-950; doi:10.2337/diacare.23.7.943
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German
BABYDIAB Study. Diabetes Care July 2000 23:969-974; doi:10.2337/diacare.23.7.969
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic
patients. Diabetes Care July 2000 23:1039-1040; doi:10.2337/diacare.23.7.1039
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care July 2000 23:893-897; doi:10.2337/diacare.23.7.893
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Diabetes Care July 2000 23:979-983; doi:10.2337/diacare.23.7.979
Hyperinsulinemia and central adiposity: influence of chronic insulin therapy in type 1 diabetes. Diabetes Care July 2000 23:1024-1025; doi:10.2337/diacare.23.7.1024
Hyperinsulinemia and central adiposity: influence of chronic insulin therapy in type 1 diabetes. Diabetes Care July 2000 23:1024-1025; doi:10.2337/diacare.23.7.1024
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic
patients. Diabetes Care July 2000 23:1039-1040; doi:10.2337/diacare.23.7.1039
High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care July 2000 23:957-961; doi:10.2337/diacare.23.7.957
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal
people from a group of remote homeland communities. Diabetes Care July 2000 23:898-904; doi:10.2337/diacare.23.7.898
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients. Diabetes Care July 2000 23:1045-1046; doi:10.2337/diacare.23.7.1045
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type
1 diabetes. Diabetes Care July 2000 23:1025-1026; doi:10.2337/diacare.23.7.1025
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care July 2000 23:957-961; doi:10.2337/diacare.23.7.957
No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients. Diabetes Care July 2000 23:1045-1046; doi:10.2337/diacare.23.7.1045
Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care July 2000 23:962-968; doi:10.2337/diacare.23.7.962
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care July 2000 23:893-897; doi:10.2337/diacare.23.7.893
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
Increased plasma plasminogen activator inhibitor 1 in relatives of type 2 diabetic patients. Diabetes Care July 2000 23:1035-1037; doi:10.2337/diacare.23.7.1035
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal
people from a group of remote homeland communities. Diabetes Care July 2000 23:898-904; doi:10.2337/diacare.23.7.898
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal
people from a group of remote homeland communities. Diabetes Care July 2000 23:898-904; doi:10.2337/diacare.23.7.898
Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose. Diabetes Care July 2000 23:1037-1038; doi:10.2337/diacare.23.7.1037
Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive
normoalbuminuric type 1 diabetic patients. Diabetes Care July 2000 23:989-993; doi:10.2337/diacare.23.7.989
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care July 2000 23:951-956; doi:10.2337/diacare.23.7.951
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal
people from a group of remote homeland communities. Diabetes Care July 2000 23:898-904; doi:10.2337/diacare.23.7.898
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care July 2000 23:951-956; doi:10.2337/diacare.23.7.951
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care July 2000 23:888-892; doi:10.2337/diacare.23.7.888
High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care July 2000 23:957-961; doi:10.2337/diacare.23.7.957
Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy. Diabetes Care July 2000 23:1031-1032; doi:10.2337/diacare.23.7.1031
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive
normoalbuminuric type 1 diabetic patients. Diabetes Care July 2000 23:989-993; doi:10.2337/diacare.23.7.989
Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care July 2000 23:893-897; doi:10.2337/diacare.23.7.893
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell
function. Diabetes Care July 2000 23:1019-1021; doi:10.2337/diacare.23.7.1019
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care July 2000 23:888-892; doi:10.2337/diacare.23.7.888
Risk for silent celiac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care July 2000 23:1027-1028; doi:10.2337/diacare.23.7.1027
High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care July 2000 23:957-961; doi:10.2337/diacare.23.7.957
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Diabetes Care July 2000 23:979-983; doi:10.2337/diacare.23.7.979
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Diabetes Care July 2000 23:979-983; doi:10.2337/diacare.23.7.979
Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose. Diabetes Care July 2000 23:1037-1038; doi:10.2337/diacare.23.7.1037
Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia? Diabetes Care July 2000 23:1022-1023; doi:10.2337/diacare.23.7.1022
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal
people from a group of remote homeland communities. Diabetes Care July 2000 23:898-904; doi:10.2337/diacare.23.7.898
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis
Study. Diabetes Care July 2000 23:1006-1011; doi:10.2337/diacare.23.7.1006
Risk for silent celiac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care July 2000 23:1027-1028; doi:10.2337/diacare.23.7.1027
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy. Diabetes Care July 2000 23:1031-1032; doi:10.2337/diacare.23.7.1031
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German
BABYDIAB Study. Diabetes Care July 2000 23:969-974; doi:10.2337/diacare.23.7.969
Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of
diabetes and precursors. Diabetes Care July 2000 23:905-911; doi:10.2337/diacare.23.7.905
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Diabetes Care July 2000 23:979-983; doi:10.2337/diacare.23.7.979
Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of
diabetes and precursors. Diabetes Care July 2000 23:905-911; doi:10.2337/diacare.23.7.905
Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver
role, and other social context factors. Diabetes Care July 2000 23:928-933; doi:10.2337/diacare.23.7.928
Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy. Diabetes Care July 2000 23:1031-1032; doi:10.2337/diacare.23.7.1031
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of
diabetes and precursors. Diabetes Care July 2000 23:905-911; doi:10.2337/diacare.23.7.905
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Assessment of insulin sensitivity: comparison between simplified evaluations and minimal model analysis. Diabetes Care July 2000 23:1038-1039; doi:10.2337/diacare.23.7.1038
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care July 2000 23:943-950; doi:10.2337/diacare.23.7.943
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care July 2000 23:951-956; doi:10.2337/diacare.23.7.951
Hyperinsulinemia and central adiposity: influence of chronic insulin therapy in type 1 diabetes. Diabetes Care July 2000 23:1024-1025; doi:10.2337/diacare.23.7.1024
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis
Study. Diabetes Care July 2000 23:1006-1011; doi:10.2337/diacare.23.7.1006
Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic
patients. Diabetes Care July 2000 23:1039-1040; doi:10.2337/diacare.23.7.1039
Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of
diabetes and precursors. Diabetes Care July 2000 23:905-911; doi:10.2337/diacare.23.7.905
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care July 2000 23:888-892; doi:10.2337/diacare.23.7.888
High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type
1 diabetes. Diabetes Care July 2000 23:1025-1026; doi:10.2337/diacare.23.7.1025
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Diabetes Care July 2000 23:979-983; doi:10.2337/diacare.23.7.979
Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune
thyroid disease. Diabetes Care July 2000 23:975-978; doi:10.2337/diacare.23.7.975
Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS. Diabetes Care July 2000 23:1018-1019; doi:10.2337/diacare.23.7.1018
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German
BABYDIAB Study. Diabetes Care July 2000 23:969-974; doi:10.2337/diacare.23.7.969
Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care July 2000 23:962-968; doi:10.2337/diacare.23.7.962